Related Experiment Video
Updated: Aug 18, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs
Mateo Porres-Aguilar1, Jack Ansell2, Debabrata Mukherjee3
1Department of Internal Medicine, Divisions of Hospital and Adult Thrombosis Medicine, Texas Tech University Health Sciences Center and Paul L. Foster School of Medicine, El Paso, Texas, USA; Sociedad Mexicana de Trombosis y Hemostasia, Ciudad de México, México.
Implementing a multidisciplinary anticoagulation stewardship program (MASP) is crucial for high-risk antithrombotic therapies. MASPs improve patient outcomes, reduce adverse events, and optimize healthcare resource use.
Area of Science:
- Pharmacology
- Clinical Medicine
- Healthcare Management
Background:
- Antithrombotic therapies, particularly anticoagulants, are essential but carry significant risks of adverse events.
- Managing these medications requires careful oversight to ensure patient safety and therapeutic efficacy.
Purpose of the Study:
- To review the critical need for antithrombosis stewardship.
- To discuss the benefits of establishing a formal multidisciplinary anticoagulation stewardship program (MASP).
Main Methods:
- Literature review and discussion of existing evidence on anticoagulation management.
- Analysis of the components and objectives of a well-functioning MASP.
Main Results:
- MASPs aim to improve patient-centered outcomes and minimize anticoagulation-related adverse events.
- These programs help reduce hospital length of stay (LOS) and associated costs.
- MASPs support clinicians, ensure resource optimization, and aid in meeting accreditation standards.
Conclusions:
- Formalized MASPs are pivotal for optimizing the use of antithrombotic therapies.
- Implementing MASPs positively impacts patient morbidity and mortality outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

